“Virtual crossmatch reveals donor-specific MICA antibodies in antibody mediated rejection: First established Indian case”
Transplant Immunology · 2025
DOI: 10.1016/j.trim.2025.102229 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transplant Immunology, 2025. Verfasst von Machiraju Sai Ravi Shankar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Seven Hills Hospital, Visakhapatnam, Andhra Pradesh, India. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, Histocompatibility Antigens Class I, Isoantibodies. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kidney transplantation is the best treatment for patients with End-stage renal disease (ESRD), offering significant improvements in their survival and quality of life. However, immune-mediated rejection of the graft remains a critical challenge. Anti-Human Leukocyte Antigen (HLA) antibodies are well-recognized mediators of acute and chronic rejection. In contrast, the role of non-HLA antibodies particularly donor-specific Anti-MHC class I-related chain A (MICA) antibodies (dsMICA Abs) requires further investigation. We report the first documented case in India of acute antibody-mediated rejection (AMR) in renal transplant recipients attributed to dsMICA. The patient, an 18-year-old male, developed graft dysfunction post-transplant despite a negative HLA Complement dependent Cytotoxicity crossmatch (CDCXM) and Lysate based Luminex Crossmatch (LumXm) results performed prior to transplantation. A more detailed diagnostic workup revealed the presence of dsMICA Abs, implicating them in the observed AMR. After a targeted treatment regimen of plasmapheresis and intravenous immunoglobulin (IVIG) therapy, the patient showed substantial clinical improvement, marked by declining creatinine levels and then restoration of renal function. This study underscores the clinical significance of dsMICA antibodies in AMR and advocates for the need for routine non-HLA antibody screening in addition to anti-HLA screening post-transplant immunological monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Seven Hills Hospital, Visakhapatnam, Andhra Pradesh, India.
- Department of Transplant Immunology, Apollo Hospitals, Jubilee Hills, Hyderabad, Telangana, India. Electronic address: drneeraja_m@apollohospitals.com.
- Department of Transfusion Medicine & Transplant, Immunology & Molecular Biology, Indraprastha Apollo Hospitals, New Delhi, India. Electronic address: mohit_c@apollohospitals.com.
- Department of Transplant Immunology & Molecular Biology, Indraprastha Apollo Hospital, New Delhi, India. Electronic address: yadav.ayushi786@gmail.com.
- Transplant Immunology & Immunogenetics Laboratory, ACTREC, Tata Memorial Center, Mumbai, India.
- Department of Pathology, Apollo Hospital, Jubilee Hills, Hyderabad, Telangana, India. Electronic address: swarnalata_g@apollohospitals.com.
Zitieren
APA
Shankar, M. S. R., Neeraja, M., Chowdhry, M., Yadav, A., Machiraju, S., Singh, M., & Gowrishanker, S. (2025). “Virtual crossmatch reveals donor-specific MICA antibodies in antibody mediated rejection: First established Indian case”. Transplant Immunology. https://doi.org/10.1016/j.trim.2025.102229
Vancouver
Shankar MSR, Neeraja M, Chowdhry M, Yadav A, Machiraju S, Singh M, et al. “Virtual crossmatch reveals donor-specific MICA antibodies in antibody mediated rejection: First established Indian case”. Transplant Immunology. 2025. doi:10.1016/j.trim.2025.102229
BibTeX
@article{Shankar2025,
author = {Shankar, Machiraju Sai Ravi and Neeraja, Mamidi and Chowdhry, Mohit and Yadav, Ayushi and Machiraju, Sriya and Singh, Meenakshi and Gowrishanker, Swarnalata},
title = {“Virtual crossmatch reveals donor-specific MICA antibodies in antibody mediated rejection: First established Indian case”},
journal = {Transplant Immunology},
year = {2025},
doi = {10.1016/j.trim.2025.102229}
}
EUVIMED